Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Life Tables01:22

Life Tables

A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population Pharmacokinetics and Exposure-Response Model-Based Bayesian Extrapolation of FVC-Based Efficacy Endpoints From Adults to Pediatric Patients Receiving Nintedanib.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Exposure-Efficacy Meta-Model of Nintedanib in Adult Patients With Chronic Fibrosing Interstitial Lung Diseases.

CPT: pharmacometrics & systems pharmacology·2025
Same author

A Pharmacometric Workflow for Resolving Model Instability in Model Use-Reuse Settings.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Evaluation of an optimized intermittent vancomycin dosing regimen in infants.

The Journal of antimicrobial chemotherapy·2025
Same author

Assessing Drug-Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption.

Pharmaceutics·2025
Same author

Less Is More: Design Considerations for Interactive Pharmacometrics Tools-A Case Study Using the Model Visualization Platform (MVP) App.

CPT: pharmacometrics & systems pharmacology·2025

Related Experiment Video

Updated: Jun 8, 2026

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

A statistical model for red blood cell survival.

Julia Korell1, Carolyn V Coulter, Stephen B Duffull

  • 1School of Pharmacy, University of Otago, P.O. Box 56, Dunedin 9054, New Zealand. julia.korell@otago.ac.nz

Journal of Theoretical Biology
|October 19, 2010
PubMed
Summary

This study introduces a statistical model for red blood cell (RBC) survival, incorporating various death causes like senescence and random destruction. The model accurately reflects RBC lifespan distributions and can be adapted for drug effects.

More Related Videos

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay
11:27

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay

Published on: February 7, 2025

An Optimized LIVE/DEAD Assay Coupled with Flow Cytometry for Quantifying Post-Stress Survival in Yeast Cells
09:58

An Optimized LIVE/DEAD Assay Coupled with Flow Cytometry for Quantifying Post-Stress Survival in Yeast Cells

Published on: August 29, 2025

Related Experiment Videos

Last Updated: Jun 8, 2026

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay
11:27

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay

Published on: February 7, 2025

An Optimized LIVE/DEAD Assay Coupled with Flow Cytometry for Quantifying Post-Stress Survival in Yeast Cells
09:58

An Optimized LIVE/DEAD Assay Coupled with Flow Cytometry for Quantifying Post-Stress Survival in Yeast Cells

Published on: August 29, 2025

Area of Science:

  • Hematology
  • Biostatistics
  • Mathematical Biology

Background:

  • Red blood cell (RBC) survival is crucial for oxygen transport.
  • Existing models may not fully capture the complex mortality patterns of RBCs.
  • Understanding RBC lifespan is vital for diagnosing and treating various hematological conditions.

Purpose of the Study:

  • To develop a comprehensive statistical model for red blood cell (RBC) survival time.
  • To incorporate a continuous distribution of cell lifespans and multiple causes of RBC death.
  • To create a flexible model amenable to studying drug effects and hematological disorders.

Main Methods:

  • Developed a statistical model based on a probability density function.
  • Utilized a bathtub-shaped hazard curve to represent RBC mortality.
  • Accounted for senescence, random destruction, initial/delayed failures, and neocytolysis.

Main Results:

  • The model generates RBC survival times consistent with previous studies.
  • The bathtub-shaped hazard curve effectively models diverse RBC death causes.
  • The model's structure allows for straightforward integration of external factors.

Conclusions:

  • The proposed statistical model provides a robust framework for analyzing RBC survival.
  • It accurately captures the continuous distribution of RBC lifespans and multifactorial mortality.
  • The model's adaptability makes it a valuable tool for future research in hematology and pharmacology.